Skip to Content

  • Search

View Additional Section Content

A Phase III, Multicenter Randomized Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety trial of Babineuzumab (AAB-001, ELN115727-301) in Patients with Mild to Moderate Alzheimer’s Disease – Non-Carriers

Principal Investigator(s)
David Weisman, M.D.
Brad Klein, M.D. (Sub-Investigator)
Lee Harris, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details